Heard on the Street: With the Food and Drug Administration's hard-liners gone, investors are rushing back into rare-disease bets

Important Notice: More than 48 hours have passed since this news or analysis was published. Due to the volatility of financial markets, some of the information or data presented may no longer be valid or reflect current market conditions. Please verify the information again before making any trading or investment decisions.